Skip to main content
OpenTrials

Clinical trial condition

Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8

Explore clinical trials studying Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 trial results

Completed

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

NCT03768414

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +27 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 692 locations
View Trial Details
Completed

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

NCT03579771

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +9 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

NCT04175912

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 419 locations
View Trial Details

Related conditions